Journal of Oriental Neuropsychiatry (동의신경정신과학회지)

The Korean Society of Oriental Neuropsychiatry (대한한방신경정신과학회)
권호 표지

Effect of SSEx on the Metabolic Syndrome in High-Fat Diet Induced Obese Mice

소풍순기원(疏風順氣元)이 고지방식이 비만 대사증후군 병태 흰쥐에 미치는 효과

  • Kim, Bo-Kyung (Dept. of Neuropsychiatry. College of Oriental Medicine. Dong-Eui University) ;
  • Oh, Young-Jin (Dept. of Neuropsychiatry. College of Oriental Medicine. Dong-Eui University) ;
  • Chun, Young-Ho (Dept. of Neuropsychiatry. College of Oriental Medicine. Dong-Eui University) ;
  • Ha, Ji-Won (Dept. of Neuropsychiatry. College of Oriental Medicine. Dong-Eui University) ;
  • Lee, Hee-Young (Dept. of Formula Science, College of Oriental Medicine, Dong-Eui University) ;
  • Jeong, Hae-Gyeong (Dept. of Formula Science, College of Oriental Medicine, Dong-Eui University) ;
  • Shin, Soon-Shik (Dept. of Formula Science, College of Oriental Medicine, Dong-Eui University) ;
  • Lee, Sang-Eon (Dept. of Neuropsychiatry, College of Oriental Medicine, Won-Kwang University)
  • 김보경 (동의대학교 한의과대학 신경정신과학교실) ;
  • 오영진 (동의대학교 한의과대학 신경정신과학교실) ;
  • 전영호 (동의대학교 한의과대학 신경정신과학교실) ;
  • 하지원 (동의대학교 한의과대학 신경정신과학교실) ;
  • 이희영 (동의대학교 한의과대학 방제학교실) ;
  • 정해경 (동의대학교 한의과대학 방제학교실) ;
  • 신순식 (동의대학교 한의과대학 방제학교실) ;
  • 이상언 (원광대학교 한의과대학 한방신경정신과 교실)
  • Received : 2010.11.15
  • Accepted : 2010.12.06
  • Published : 2010.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : We investigated the effects of Sopungsungj-won(Shufengshunqjvuan) (SSEx1, SSEx2) on the metabolic syndrome in high-fat diet induced obese mice. Methods: 8 weeks old, high fat diet induced obese male mice were divided into 4 groups: C57BL/6 lean control, obese vehicle control, SSEx1, SSEx2. After mice were treated with SSExl, SSEx2 for 12 weeks, we measured body weight gain, food intake, feeding efficiency ratio, fat weight, plasma leptin, insulin, glucose and lipid levels. We also observe the morphology and count for the numbers of Adipocyte and evaluate the weight of organs and it's function. Results: 1. Compared to Obese Control Group, SSEx1 gained significantly lower body weight and showed lower Feeding Efficiency Ratio. 2. Compared to Obese Control Group, SSEx1 showed lower weights of epididymal adipose tissue, troperitoneal adipose tissue, inguinal adipose tissue, brown adipose tissue. SSEx2 showed higher weights of epididymal adipose tissue, troperitoneal adipose tissue, inguinal adipose tissue, brown adipose tissue. 3. Compared to Obese Control Group, the size of adipocytes was significantly decreased by SSEx1, whereas the number of adipocites per unit was significantly increased. Hepatic lipid accumulation was decreased significantly by SSEx1. 4. Concerning the weights of Liver, Heart, Spleen, Kidney and Pancreas, SSEx1, SSEx2 showed little differences with those of Lean Control, Obese Control. 5. Compared to Obese Control Group, SSEX1, SSEx2 showed lower level of plasma triglyceride, but SSEx1 had significance only. SSEx1, SSEx2 showed little lower level of plasma HDL-cholesterol. LDL-cholesterol, total cholesterol, but had no significances. 6. Concerning the levels of plasma glucose, insulin and leptin, SSEx1 and SSEx2 showed littele changes with those of Lean Control, Obese Control. 7. The leves of Plasma AST, AST, ALT, free fatty acid, BUN, creatinine were in the physiological range at 4 groups all: Lean Control, Obese Control, SSEx1, SSEx2. Conclusions : These results showed SSEx1 can be used as therapeutic agent for Obesity and metabolic syndrome caused by long-period high fat diet.

Keywords

Acknowledgement

Supported by : 동의대학교

References

  1. Journal of the American Medical Association (JAMA). National Cholesterol Education Program:Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults(adult treatment panel III). Circulation. 2001;285:2488-97.
  2. 권혁상. 대사증후군의 역학 및 병인. 대한당뇨병학회지. 2006;7(1):12-9.
  3. 임수, 이은정, 구보경, 조성일, 박경수, 장학철, 김성연, 이홍규. 국민건강영양조사에 근거한 한국인의 대사증후군의 증가양상. 당뇨병학회지. 2005;19(5):432-9.
  4. 허준. 동의보감. 서울:법인문화사. 1999:140, 470, 945, 948, 962, 964.
  5. 任漢陽 등. 火麻仁油的降脂及對過氧化脂質作用的實驗硏究. 중국중의약과지. 1997;4(4):200.
  6. Mason AP, McBay AJ. Cannabis:Pharmacokinetics and Interpretation of Effects. J. Forensics Sciencs. 1985;30(3):615-31.
  7. 정재욱. 중풍환자의 변비에 대한 소풍순기원의 임상적 연구. 동의대학교 석사학위논문. 2005.
  8. 이성현, 안세영, 두호경, 정성현. db/db 마우스에서 수풍순기환의 혈당강하 및 기전연구. 응용약물학회지. 1999;7:335-41.
  9. 배미라, 정성현. 고지방식이 섭취 마우스에서 수풍순기환의 혈당강하활성 및 기전. 경희약대논문집. 2000;28:101-8.
  10. 곡경내, 김종우, 정선용, 박지호. 뇌해마배양 조직을 이용한 치매 뇌손상 모델에 대한 소풍순기원과 환련해독탕 처방약재의 신경보호 효과. 동의신경정신과학회지. 2010;21(1):43-58.
  11. 오영진, 신순식, 윤미정, 김보경. 소풍순기원이 mouse의 NMu2Li간세포와 C2C12 골격근세포에서 PPARs조절의 분자기전에 미치는 영향. 동의신경정신과학회지. 2009;20(1):147-64.
  12. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1999;37:1595-607.
  13. 이기업. 대사증후군의 치료. 한국지질동맥경화학회지. 2002;12(1):31-5.
  14. 危亦林. 世醫得效方. 北京:中國中醫藥出版社. 1996:98.
  15. 양유걸. 황제내경소문역해. 서울:성보사. 1998:19.
  16. 진월인. 난경입문. 서울:법인문화사. 1998:338-40.
  17. 武市昌士. 미병의 동서의학. 서울:군자출판사. 2008:23-5.